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ABSTRACT
Introduction Body mass index (BMI) and waist 
circumference (WC) cut- offs associated with 
hyperglycemia may differ by ethnicity. We investigated the 
optimal BMI and WC cut- offs for identifying hyperglycemia 
in the predominantly Afro- Caribbean population of 
Barbados.
Research design and methods A cross- sectional study 
of 865 individuals aged ≥25 years without known diabetes 
or cardiovascular disease was conducted. Hyperglycemia 
was defined as fasting plasma glucose ≥5.6 mmol/L or 
hemoglobin A1c ≥5.7% (39 mmol/mol). The Youden index 
was used to identify the optimal cut- offs from the receiver 
operating characteristic (ROC) curves. Further ROC analysis 
and multivariable log binomial regression were used to 
compare standard and data- derived cut- offs.
Results The prevalence of hyperglycemia was 58.9% 
(95% CI 54.7% to 63.0%). In women, optimal BMI and 
WC cut- offs (27 kg/m2 and 87 cm, respectively) performed 
similarly to standard cut- offs. In men, sensitivities of the 
optimal cut- offs of BMI ≥24 kg/m2 (72.0%) and WC ≥86 cm 
(74.0%) were higher than those for standard BMI and WC 
obesity cut- offs (30.0% and 25%–46%, respectively), 
although with lower specificity. Hyperglycemia was 
70% higher in men above the data- derived WC cut- off 
(prevalence ratio 95% CI 1.2 to 2.3).
Conclusions While BMI and WC cut- offs in Afro- Caribbean 
women approximate international standards, our findings, 
consistent with other studies, suggest lowering cut- 
offs in men may be warranted to improve detection 
of hyperglycemia. Our findings do, however, require 
replication in a new data set.
INTRODUCTION
Diabetes is a leading cause of morbidity 
and mortality worldwide1 2 and the English- 
speaking Caribbean subregion of the Amer-
icas is no exception. In 2016, mortality from 
diabetes mellitus in these countries was nearly 
twice the regional average (64.9 vs 33.5 per 
100 000),3 and Afro- Caribbean ancestry is 
recognized as a risk factor for the develop-
ment of diabetes.4 The impact of diabetes on 
the small economies of Caribbean countries 
is significant—in four Caribbean countries, 
the economic cost of diabetes, combined with 
hypertension, was estimated to be between 
1% and 8% of gross domestic product.5 While 
policy interventions which successfully target 
unhealthy behaviors can reduce population 
risk,6 identifying individuals with undiag-
nosed diabetes and those with intermediate 
hyperglycemia or pre- diabetes, who are at 
higher risk of developing diabetes and would 
benefit from intervention, is also an effective 
and necessary strategy to decrease diabetes 
morbidity and mortality.7
Widespread biochemical testing for diabetes 
in the Caribbean is, however, impractical 
and risk factors which can be easily assessed 
are essential to developing a cost- effective 
screening strategy. While international guide-
lines identify excess weight as one such risk 
factor for type 2 diabetes,4 existing data 
suggest that associations between adiposity 
Significance of this study
What is already known about this subject?
 ► Body mass index and waist circumference cut- 
offs associated with hyperglycemia may differ by 
ethnicity.
What are the new findings?
 ► Standard definitions of generalized and abdominal 
obesity have poor sensitivity in detecting prevalent 
hyperglycemia in Afro- Caribbean men.
 ► The population- specific body mass index and waist 
circumference thresholds for optimally detecting hy-
perglycemia in Afro- Caribbean men are, at 24 kg/m2 
and 86 cm respectively, lower than standard obesity 
definitions.
How might these results change the focus of 
research or clinical practice?
 ► Modifying obesity definitions in Afro- Caribbean 
men may be warranted to improve detection of 
hyperglycemia.
2 BMJ Open Diab Res Care 2021;9:e002246. doi:10.1136/bmjdrc-2021-002246
Epidemiology/Health services research
and hyperglycemic risk differ by ethnicity.8 Consequently, 
widely accepted anthropometric cut- offs for overweight 
and obesity, whether based on body mass index (BMI) or 
waist circumference (WC), may not, in fact, identify Afro- 
Caribbean individuals who are at higher risk of hyper-
glycemia. Appropriately defined BMI and WC cut- offs 
remain, however, potentially inexpensive, simply imple-
mented strategies for identifying individuals who would 
benefit from further investigation and additional work in 
this area is therefore necessary.
Our objective, using the approach adopted in other 
studies,9 10 was to investigate the optimal BMI and WC cut- 
offs for discriminating between those with and without 
hyperglycemia on the Caribbean island of Barbados, 
which has a high prevalence of pre- diabetes, diabetes 
and diabetes- related complications.11–14 We compared 
population- specific and international standard cut- 
offs and hypothesized that the population- specific cut- 
offs would have better performance characteristics in 
detecting individuals likely to have undiagnosed hyper-
glycemia (pre- diabetes and diabetes) and thus requiring 
further evaluation. In addition, our findings might 
inform the definition of optimal anthropometric indices 
in this population and in similar populations of primarily 
African descent.
RESEARCH DESIGN AND METHODS
The survey methodology has been described in detail 
elsewhere.11 14 In brief, a cross- sectional survey was 
undertaken between September 2011 and May 2013 in 
adults aged ≥25 years in Barbados, an English- speaking 
country in the eastern Caribbean of approximately 280 
000 individuals, 92.4% of whom are of African descent. 
Study data were collected by 11 fieldworkers who under-
went training and accreditation sessions, which included 
ensuring that they followed the study’s standard oper-
ating procedures for measurement of height, weight and 
waist circumference. The training sessions were repeated 
during the survey. In addition, each fieldworker had a 
minimum of three supervised visits before collecting data 
independently. Demographic, behavioral and medical 
history data were collected using the Pan- American 
modification of the WHO STEPwise Approach to Non- 
Communicable Disease Surveillance questionnaire.15 
Anthropometric and clinical measurements for a given 
study participant, including weight, standing height 
and WC, were performed by a single observer. WC was 
measured horizontally at the midpoint between the lower 
rib and the iliac crest in the mid- axillary line. Two initial 
measurements were taken, with a third measurement 
taken if the first two differed by more than 0.5 cm, and 
the mean of the two closest measurements was used in 
the analysis. BMI was calculated as weight in kilograms 
divided by height in meters squared.
Venous blood samples were collected after a minimum 
9- hour fast in sodium fluoride and EDTA tubes for 
glucose and hemoglobin A1c (HbA1c) assays, respectively.
Laboratory analysis
Plasma glucose was assayed using a glucohexokinase 
method (Roche Cobas 6000, Roche Diagnostics, Mann-
heim, Germany) and HbA1c was assayed using a National 
Glycohemoglobin Standardization Program- traceable 
DCA 2000 analyzer (Siemens Healthcare Diagnostics, 
Munich, Germany). As described in detail elsewhere,14 
HbA1c analyses on 56 samples were performed using both 
the DCA 2000 analyzer and high- performance liquid 
chromatography at the American College of Pathology- 
accredited Barbados Reference Laboratory, and a regres-
sion equation was developed to adjust the results from 
the DCA 2000 analyzer so they were comparable with 
those obtained at the national reference laboratory.




We used standard definitions, namely BMI ≥30 kg/m2 for 
generalized obesity and BMI ≥25 kg/m2 for generalized 
overweight and obesity. We used two different definitions 
for abdominal obesity: the International Diabetes Feder-
ation (IDF) definition of WC ≥80 cm in women and 94 cm 
in men16 and the American Heart Association/National 
Heart, Lung, and Blood Institute (AHA/NHLBI) modi-
fication of the Adult Treatment Panel III definition of 
WC ≥88 cm in women and 102 cm in men.17
Hyperglycemia
We defined hyperglycemia using the American 
Diabetes Association (ADA) criteria of fasting plasma 
glucose ≥5.6 mmol/L or HbA1c ≥5.7% (39 mmol/mol).
18 
We performed sensitivity analyses using the WHO criteria 
of fasting plasma glucose ≥6.1 mmol/L or HbA1c ≥6% (42 
mmol/mol).
Statistical analysis
As our aim was to identify those with undiagnosed pre- 
diabetes or diabetes, individuals who reported a previous 
diagnosis of diabetes were excluded from the analysis. We 
also excluded those who reported a previous diagnosis of 
vascular disease, such as stroke or ischemic heart disease, 
given that individuals with these conditions would require 
assessment of their glycemic status.
Weights were applied to account for the sampling 
design and non- response and to match the age and sex 
distribution of the Barbadian population according to 
the 2010 census. Full details of the weighting scheme are 
available online in appendix 1 of Howitt et al.11 Preva-
lence estimates with 95% CIs are presented overall and 
for subgroups defined by sex.
We used the same approach to investigating cut- offs as 
Ekoru et al,9 who investigated the appropriate WC cut- 
offs to identify metabolic risk in sub- Saharan African 
populations. The ability of BMI and WC to discrimi-
nate between those with and without hyperglycemia was 
summarized using the area under the curve (AUC) of 
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the receiver operating characteristic (ROC) curves strat-
ified by sex. The Youden index for the ROC curve for 
each anthropometric measurement was selected as the 
optimal data- derived cut- off. The sensitivity, specificity, 
positive predictive value and negative predictive value of 
both standard and data- derived cut- offs for BMI and WC 
in detecting hyperglycemia were then determined.
Log binomial regression models, adjusted for age, 
were fitted to investigate the strength of association (as 
adjusted prevalence ratios) between standard and data- 
derived cut- offs and hyperglycemia.
Data were analyzed using Stata statistical software 
(V.13).
RESULTS
Of the 1234 individuals recruited to the study, 226 had 
known diabetes and/or cardiovascular disease and were 
excluded from the analysis. A further 143 individuals 
were excluded due to missing data (69.2% with missing 
fasting plasma glucose and/or HbA1c and 30.8% with 
missing WC and/or BMI). Those excluded due to missing 
data did not differ in age from those who were included 
(mean age 46.7 years vs 46.8 years) but were more likely 
to be female (p=0.039).
Eight hundred and sixty- five participants were included 
in the analysis and their characteristics are shown in 
table 1. The mean age (SD) of the weighted sample was 
46.8 (14.8) years and 50.4% of the participants were 
female. All generalized and abdominal obesity indices 
were higher in women than in men. Over a quarter of 
the population had hyperglycemia based on the WHO 
criteria and over half based on the ADA criteria. The 
prevalence of total hyperglycemia was higher in women 
for both WHO and ADA criteria but 95% CIs were 
overlapping.
The ROC curves for BMI and WC, stratified by sex, are 
shown in figure 1, and the performance characteristics of 
the standard and data- derived cut- offs for detecting ADA- 
defined hyperglycemia are shown in table 2. In women, 
the data- derived BMI cut- off of 27 kg/m2 was intermediate 
Table 1 Demographic, anthropometric and biochemical characteristics of participants
Women, n=519 (436)* Men, n=346 (429)* Overall, n=865 (865)*
Mean age (SD) (years) 47.3 (16.2) 46.4 (13.3) 46.8 (14.8)
Number by age group in years
  25–44* 222 (214) 136 (224) 358 (439)
  45–64* 225 (164) 147 (150) 372 (314)
  65+* 72 (57) 63 (55) 135 (113)
Anthropometry
  Mean BMI (SD) (kg/m2) 29.8 (8.2) 26.4 (4.6) 28.1 (6.7)
  Mean waist circumference (SD) (cm) 92.6 (16.1) 90.0 (12.0) 91.3 (14.1)
  % BMI ≥25 kg/m2 73.9 (69.1 to 78.3) 55.7 (48.3 to 62.8) 64.9 (60.6 to 68.9)
  % BMI ≥30 kg/m2 42.5 (37.7 to 47.4) 22.3 (17.4 to 28.1) 32.5 (28.8 to 36.4)
  % IDF abdominal obesity 80.1 (75.6 to 84.0) 35.0 (27.9 to 42.8) 57.7 (52.4 to 62.9)
  % AHA/NHLBI abdominal obesity 58.6 (54.1 to 63.0) 18.0 (13.6 to 23.3) 38.4 (34.4 to 42.6)
Measures of glycemia
  Mean fasting plasma glucose (SD) (mmol/L) 5.3 (1.4) 5.2 (0.8) 5.3 (1.1)
  Mean HbA1c (SD) (%) 5.8 (0.8) 5.7 (0.4) 5.7 (0.6)
  Mean HbA1c (SD) (mmol/mol) 40 (8.7) 39 (4.4) 39 (6.6)
Hyperglycemia (ADA categories)
  % fasting plasma glucose ≥5.6 mmol/L 21.1 (16.8 to 26.2) 22.6 (18.2 to 27.7) 21.9 (18.8 to 25.3)
  % HbA1c ≥5.7% (39 mmol/mol) 58.9 (54.6 to 63.0) 49.4 (42.9 to 55.9) 54.2 (50.1 to 58.1)
  % total hyperglycemia 63.5 (59.2 to 67.7) 54.3 (47.3 to 61.1) 58.9 (54.7 to 63.0)
Hyperglycemia (WHO categories)
  % fasting plasma glucose ≥6.1 mmol/L 9.8 (6.8 to 14.0) 9.8 (7.0 to 13.6) 9.8 (7.6 to 12.6)
  % HbA1c ≥ 6.0% (42 mmol/mol) 27.6 (23.2 to 32.5) 21.8 (17.6 to 26.5) 24.7 (21.6 to 28.1)
  % total hyperglycemia 29.7 (24.9 to 35.0) 25.2 (20.4 to 30.6) 27.5 (24.0 to 31.3)
*Number of participants: numbers in brackets are weighted values as described in the text. Prevalence is given as point estimates with 95% 
CIs.
ADA, American Diabetes Association; AHA, American Heart Association; BMI, body mass index; HbA1c, hemoglobin A1c; IDF, International 
Diabetes Federation; NHLBI, National Heart, Lung, and Blood Institute; WHO, World Health Organization.
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between the standard BMI cut- offs for overweight and 
obesity, with intermediate sensitivity and specificity and 
similar ability to discriminate between those with and 
without ADA- defined hyperglycemia. The data- derived 
cut- off for abdominal obesity in women (WC ≥87 cm) 
approximated the AHA/NHLBI cut- off (WC ≥88 cm) 
with, as expected, lower sensitivity but higher specificity 
than the IDF cut- off (WC ≥80 cm). Areas under the ROCs 
Figure 1 Receiver operating characteristic curves for hyperglycemia by BMI and WC. The positions of the data- derived cut 
points, standard BMI cut points and WC cut points of IDF and AHA/NHLBI are shown. AHA, American Heart Association; 
BMI, body mass index; IDF, International Diabetes Federation; NHLBI, National Heart, Lung, and Blood Institute; WC, waist 
circumference.
Table 2 Characteristics of standard and data- derived BMI and waist cut- offs for detection of hyperglycemia, based on the 
American Diabetes Association categories
AUC Sensitivity (%) Specificity (%) PPV (%) NPV (%) Youden index
BMI ≥25 kg/m2
  Women 57.1 (52.5 to 61.7) 79.0 (73.0 to 85.0) 35.0 (28.0 to 43.0) 68.0 (63.0 to 73.0) 49.0 (40.0 to 59.0) 0.14
  Men 59.4 (52.6 to 66.2) 64.0 (54.0 to 73.0) 54.0 (44.0 to 64.0) 63.0 (54.0 to 70.0) 56.0 (45.0 to 67.0) 0.19
BMI ≥30 kg/m2
  Women 57.6 (52.3 to 63.0) 48.0 (42.0 to 54.0) 67.0 (58.0 to 75.0) 72.0 (64.0 to 78.0) 43.0 (36.0 to 49.0) 0.15
  Men 58.1 (52.4 to 63.8) 30.0 (22.0 to 38.0) 86.0 (77.0 to 92.0) 72.0 (57.0 to 84.0) 51.0 (42.0 to 59.0) 0.16
BMI (data- derived)
  Women (≥27 kg/m2) 57.8 (52.4 to 63.2) 63.0 (56.0 to 69.0) 53.0 (44.0 to 61.0) 70.0 (64.0 to 75.0) 45.0 (37.0 to 53.0) 0.16
  Men (≥24 kg/m2) 61.9 (55.9 to 67.8) 72.0 (64.0 to 79.0) 51.0 (41.0 to 61.0) 64.0 (56.0 to 71.0) 61.0 (50.0 to 71.0) 0.24
Abdominal obesity (IDF)
  Women (WC ≥80 cm) 61.7 (57.3 to 66.1) 89.0 (84.0 to 92.0) 35.0 (27.0 to 44.0) 70.0 (66.0 to 74.0) 64.0 (52.0 to 74.0) 0.24
  Men (WC ≥94 cm) 62.3 (55.9 to 68.8) 46.0 (37.0 to 56.0) 79.0 (67.0 to 87.0) 72.0 (61.0 to 81.0) 55.0 (45.0 to 64.0) 0.25
Abdominal obesity (AHA/NHLBI)
  Women (WC ≥88 cm) 62.9 (57.6 to 68.2) 68.0 (62.0 to 74.0) 58.0 (50.0 to 65.0) 74.0 (68.0 to 79.0) 51.0 (43.0 to 59.0) 0.26
  Men (WC ≥102 cm) 57.7 (52.8 to 62.7) 25.0 (18.0 to 33.0) 90.0 (83.0 to 95.0) 76.0 (59.0 to 87.0) 50.0 (42.0 to 58.0) 0.16
Abdominal obesity (data- derived)
  Women (WC ≥87 cm) 63.7 (58.3 to 69.1) 71.0 (65.0 to 77.0) 56.0 (47.0 to 64.0) 74.0 (68.0 to 79.0) 53.0 (44.0 to 61.0) 0.28
  Men (WC ≥86 cm) 66.2 (59.9 to 72.6) 74.0 (65.0 to 81.0) 59.0 (48.0 to 69.0) 68.0 (60.0 to 75.0) 65.0 (54.0 to 76.0) 0.34
Relevant findings using WHO categories of hyperglycemia are described in the text.
AHA, American Heart Association; AUC, area under the curve; BMI, body mass index; IDF, International Diabetes Federation; NHLBI, National Heart, Lung, and 
Blood Institute; NPV, negative predictive value; PPV, positive predictive value; WC, waist circumference.
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were, however, similar for all three cut- offs. The CIs for 
the negative and positive predictive values for the stan-
dard cut- offs overlapped with those for the data- derived 
cut- offs for both BMI and WC.
For men, in contrast to women, the data- derived cut- off 
for BMI (≥24 kg/m2) was closer to the standard cut- off 
for overweight than to the cut- off for generalized obesity. 
As expected, the lower values were more sensitive but 
less specific and had similar ability to standard cut- offs 
in discriminating between those with and without hyper-
glycemia. The data- derived WC cut- off in men was 86 cm, 
lower than both the IDF cut- off of 94 cm and the AHA/
NHLBI cut- off of 102 cm, with a higher negative predic-
tive value than either standard cut- off but no clear differ-
ence in positive predictive value.
Similar anthropometric cut- offs were obtained when 
repeating the analyses using the WHO criteria for hyper-
glycemia. In women, the data- derived BMI cut- off was 
29 kg/m2, with a Youden index of 0.20, and in men it 
was 23 kg/m2 (Youden 0.24). In women, the WC cut- off 
was 87 cm, similar to that obtained using ADA- defined 
hyperglycemia (Youden 0.31), while in men it was 88 cm 
(Youden 0.35). AUC, sensitivity and specificity for BMI 
and WC cut- offs for detecting WHO- defined hypergly-
cemia were similar to those for detecting ADA- defined 
hyperglycemia. As would be expected, given the lower 
prevalence of WHO- defined hyperglycemia, the posi-
tive predictive values for these data- derived indices were 
lower and the negative predictive values higher than with 
ADA- defined hyperglycemia. The WC cut- off of 86 cm 
in men, for example, had a positive predictive value for 
WHO- defined hyperglycemia of 35.9% (95% CI 28.6 
to 42.8), while the negative predictive value was 90.1% 
(95% CI 83.0 to 94.5).
In contrast to standard cut- offs, the use of data- derived 
cut- offs resulted in similar prevalence of generalized 
and abdominal obesity in men and women, as shown 
in table 3. Irrespective of the criterion used, individuals 
above the obesity cut- offs had a higher age- adjusted prev-
alence of ADA- defined hyperglycemia than those below 
(table 4). Prevalence ratios for BMI cut- offs in women 
ranged between 1.2 and 1.3, while those for WC were 
between 1.4 and 1.8. In men, there was 30%–50% higher 
prevalence of hyperglycemia in those above the BMI 
thresholds and 30%–70% higher prevalence in those 
above the WC thresholds. Prevalence ratios were even 
higher when the more conservative WHO definition of 
hyperglycemia was used.
DISCUSSION
Undiagnosed diabetes and pre- diabetes are prevalent 
in the Caribbean island of Barbados, where between a 
quarter and a half of adults in our survey were found to 
be hyperglycemic, depending on the definition used. In 
women, population- specific BMI and WC cut- offs were 
similar to existing cut- offs, with comparable perfor-
mance in discriminating between those with and without 
hyperglycemia, whereas in men the data- derived cut- offs 
for both BMI and WC were lower than the standard cut- 
offs, with the WC cut- off having better negative predica-
tive value than standard values. Use of lower cut- offs in 
men more than doubled the prevalence of obesity, with 
a higher prevalence ratio of hyperglycemia in men above 
the data- derived WC cut- off than in those above standard 
WC cut- offs.
Table 3 Prevalence of generalized and abdominal obesity in women and men based on data- derived cut- offs for American 
Diabetes Association- defined hyperglycemia
Women Men All
Generalized obesity (%) 57.3 (52.4 to 62.1) 61.6 (54.9 to 68.0) 59.5 (56.0 to 62.8)
Abdominal obesity (%) 61.5 (56.1 to 66.6) 58.9 (51.6 to 65.9) 60.2 (55.6 to 64.7)
Figures are given as weighted percentages with 95% CIs.
Table 4 Age- adjusted prevalence ratios for hyperglycemia 
defined by ADA and WHO using standard and data- derived 
cut- offs for generalized and abdominal obesity




  ADA- defined hyperglycemia 1.3 (1.1 to 1.6) 1.3 (1.0 to 1.7)
  WHO- defined hyperglycemia 1.9 (1.3 to 2.9) 1.5 (0.9 to 2.4)
BMI ≥30 kg/m2
  ADA- defined hyperglycemia 1.2 (1.0 to 1.4) 1.4 (1.2 to 1.7)
  WHO- defined hyperglycemia 1.7 (1.2 to 2.2) 1.6 (1.1 to 2.2)
Data- derived
  ADA- defined hyperglycemia 1.2 (1.1 to 1.4) 1.5 (1.1 to 1.9)
  WHO- defined hyperglycemia 1.7 (1.3 to 2.3) 1.8 (1.1 to 3.1)
Abdominal obesity
IDF criteria
  ADA- defined hyperglycemia 1.8 (1.3 to 2.4) 1.4 (1.1 to 1.7)
  WHO- defined hyperglycemia 2.9 (1.6 to 5.2) 1.6 (1.1 to 2.3)
AHA/NHLBI criteria
  ADA- defined hyperglycemia 1.4 (1.2 to 1.7) 1.3 (1.1 to 1.7)
  WHO- defined hyperglycemia 2.4 (1.5 to 3.6) 1.6 (1.1 to 2.4)
Data- derived
  ADA- defined hyperglycemia 1.5 (1.2 to 1.8) 1.7 (1.2 to 2.3)
  WHO- defined hyperglycemia 2.8 (1.9 to 4.2) 2.7 (1.6 to 4.5)
ADA, American Diabetes Association; AHA, American Heart Association; 
BMI, body mass index; IDF, International Diabetes Federation; NHLBI, 
National Heart, Lung, and Blood Institute; WHO, World Health Organization.
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Previous studies have highlighted the need for 
ethnicity- specific anthropometric cut- offs in identifying 
Afro- Caribbean people at risk of hyperglycemia. An age- 
adjusted and sex- adjusted BMI cut- off of 27.2 kg/m2 in 
Afro- Caribbean individuals living in the UK was associated 
with a diabetes incidence rate, after a median follow- up 
of 19 years, equivalent to a BMI of 30 kg/m2 in Euro-
peans, while WC of 81.2 cm in Afro- Caribbean women 
and 90.4 cm in Afro- Caribbean men was associated with 
age- adjusted incidence rates of diabetes similar to those 
in Europeans with WC of 88 cm and 102 cm in men and 
women, respectively.19 In a longitudinal study in Jamaica, 
BMI cut- offs of 29.3 kg/m2 in women and 24.8 kg/m2 in 
men and WC cut- offs of 84.5 cm in women and 88 cm in 
men were optimal in predicting incident diabetes during 
a mean 4- year follow- up.20 These studies suggest that 
while standard BMI and WC cut- offs may be appropriate 
in women, they may be less applicable in men, who may 
have a higher risk of hyperglycemia at a lower degree of 
adiposity. The reasons for these ethnic differences remain 
unclear, however. Visceral fat, for example, may be impli-
cated in the pathogenesis of type 2 diabetes, but appears 
to be lower in Afro- Caribbean individuals compared with 
those of European descent,21 despite the higher risk of 
hyperglycemia. Factors other than adipose tissue distri-
bution and function may therefore play a significant role 
in the development of hyperglycemia in individuals of 
African descent.22 Interestingly, the UK study, unlike our 
study and the work conducted in Jamaica, did not find a 
sex difference in optimal BMI, but this may be attribut-
able to potential differences in Afro- Caribbean migrants 
when compared with Afro- Caribbean populations in the 
Caribbean. Our study complements this longitudinal 
work by identifying cut- offs that can be used to identify 
individuals at risk of prevalent hyperglycemia who would 
benefit from further clinical investigation.
Our study provides further data to support the use of 
population- derived cut- offs to define both generalized 
and abdominal obesity. Work in sub- Saharan African 
populations, although investigating metabolic risk, also 
highlighted the need for population- specific cut- offs.9 
Such cut- offs, in addition to identifying individuals 
at risk, could also inform public health messaging on 
appropriate BMI and WC thresholds in Afro- Caribbean 
populations, who are at high risk of developing diabetes 
and diabetes- related complications. The use of lower cut- 
offs in men would, however, increase the prevalence of 
obesity and in turn increase the number of individuals 
identified for hyperglycemia screening with the associ-
ated costs. This additional cost to the healthcare system 
needs to be weighed against the advantages of the lower 
diabetes morbidity and mortality that could result from 
earlier detection and intervention.
Our study does have limitations. Our sample size was small, 
which was reflected in the broad and overlapping CIs. The 
survey response rate was 55%,11 and while somewhat low, 
this is comparable with similar surveys in high- income coun-
tries, with the National Health and Nutrition Examination 
Survey in the USA reporting an unweighted response rate of 
48.8% for completion of the interview and examination in 
2017–201823 and the Health Survey for England reporting a 
response rate of 55% in adults in 2017.24 We did, however, 
apply sample weights to ensure the sample was more repre-
sentative of the background population. Given that ADA 
and WHO guidelines promote use of HbA1c to identify 
hyperglycemia, we included it in our definition, but this 
may have overestimated the prevalence of hyperglycemia in 
our sample as current HbA1c thresholds may overdiagnose 
hyperglycemia in populations of African ancestry.14 Due to 
our sample size, we were unable to investigate whether the 
relationship between anthropometric measures and hyper-
glycemia varies with age. Despite these limitations, our study, 
which is to our knowledge one of the first in the Caribbean, 
adds to the growing literature on appropriate anthropo-
metric cut points in Afro- Caribbean populations.
In conclusion, optimal BMI and WC cut- offs for 
discriminating between Afro- Caribbean individuals with 
and without hyperglycemia appear, in men, to be lower 
than internationally accepted cut- offs. Validation of our 
data- derived cut- offs through replication of our findings 
in a new data set is, however, necessary.
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